checkAd

     388  0 Kommentare A Research Consortium Under the Direction of Grünenthal Will Receive a Grant of €1.5 million From the European Fund for Regional Development and the Federal State of North Rhein-Westphalia - Seite 3

    The Federal State of North Rhein-Westphalia (NRW) initiated the Leitmarktwettbewerb LifeSciences.NRW, a funding competition, in 2015 to develop solutions to challenges in the field of health and well-being for our aging population. This initiative offers funding opportunities for groups of small and medium-sized enterprises, academic institutions and pharmaceutical companies in North Rhein-Westphalia, for innovative projects in research and development with resources provided by the EU and the State of North Rhein-Westphalia. By supporting innovation, the State of North Rhein-Westphalia wishes to secure sustainable growth and employment opportunities, and increase its international visibility as a leading location for Life Sciences.

    About Grünenthal 

    The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.

    Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: http://www.grunenthal.com.

    Literature 

    1: van Hecke O. et al, Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014 Apr;155(4):654-62

    Contact: Steffen Fritzsche, Head Corporate Communications
    Tel.: +49-241-569-1335, Fax.: +49-241-569-51335, steffen.fritzsche@grunenthal.com

    Grünenthal GmbH, 52099 Aachen, Germany, http://www.grunenthal.com

    Seite 3 von 3



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    A Research Consortium Under the Direction of Grünenthal Will Receive a Grant of €1.5 million From the European Fund for Regional Development and the Federal State of North Rhein-Westphalia - Seite 3 AACHEN, Germany, September 27, 2016 /PRNewswire/ - Research grant awarded by Leitmarktwettbewerb LifeSciences.NRW to improve the development of new analgesic drugs  The consortium members, founded and led by Grünenthal, are from the University …